180 related articles for article (PubMed ID: 25686836)
1. Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival.
Zhu Q; Li N; Zeng X; Han Q; Li F; Yang C; Lv Y; Zhou Z; Liu Z
Oncotarget; 2015 Feb; 6(6):4440-50. PubMed ID: 25686836
[TBL] [Abstract][Full Text] [Related]
2. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
[TBL] [Abstract][Full Text] [Related]
4. The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?
Yim SY; Seo YS; Jung CH; Kim TH; Lee JM; Kim ES; Keum B; Jong YK; An H; Kim JH; Yim HJ; Kim DS; Jeen YT; Yeon JE; Lee HS; Chun HJ; Byun KS; Um SH; Kim CD; Ryu HS
Liver Int; 2016 Mar; 36(3):445-53. PubMed ID: 26352789
[TBL] [Abstract][Full Text] [Related]
5. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.
Park JW; Chen M; Colombo M; Roberts LR; Schwartz M; Chen PJ; Kudo M; Johnson P; Wagner S; Orsini LS; Sherman M
Liver Int; 2015 Sep; 35(9):2155-66. PubMed ID: 25752327
[TBL] [Abstract][Full Text] [Related]
6. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
Zhang DZ; Wei XD; Wang XP
World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
[TBL] [Abstract][Full Text] [Related]
8. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
9. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics, treatment patterns and survival outcome of hepatocellular carcinoma patients aged 70 years or older: a single-center retrospective study from China.
Fan C; Jin G; Sun C; Ma D; Chen C; Qiao P; Wu D
Aging Clin Exp Res; 2014 Apr; 26(2):123-30. PubMed ID: 24129805
[TBL] [Abstract][Full Text] [Related]
11. The changing scenario of hepatocellular carcinoma over the last two decades in Italy.
Santi V; Buccione D; Di Micoli A; Fatti G; Frigerio M; Farinati F; Del Poggio P; Rapaccini G; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Bernardi M; Trevisani F
J Hepatol; 2012 Feb; 56(2):397-405. PubMed ID: 21756850
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma.
Yeh ML; Huang CI; Huang CF; Hsieh MY; Huang JF; Dai CY; Lin ZY; Chen SC; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2015 Feb; 31(2):77-82. PubMed ID: 25645985
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
16. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
17. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study.
Liu Y; Yang R
J Vasc Interv Radiol; 2009 Apr; 20(4):472-83. PubMed ID: 19250841
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Survival in Hepatocellular Carcinoma Patients.
Gokcan H; Savaş N; Oztuna D; Moray G; Boyvat F; Haberal M
Ann Transplant; 2015 Oct; 20():596-603. PubMed ID: 26438974
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate.
Radu P; Groza I; Iancu C; Al Hajjar N; Andreica V; Sparchez Z
J Gastrointestin Liver Dis; 2013 Sep; 22(3):291-7. PubMed ID: 24078986
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]